Figure 1.
Progression-free survival (PFS) from the treatment initiation of patients with VEGF-A rs699947 A/A vs. C/C (31.1 vs. 10.1 months, p = 0.006).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.